Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 5/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.49 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.49 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.46 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31532946 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL1409002 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL19816770 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL1408891 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL346746 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL1409041 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL7552315 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL285321 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL12006469 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL21842271 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2295438-B2 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | TOSOH CORP (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-3271289-B1 | FUNCTIONALIZED GRAPHENE BARRIER ELEMENT | NITTO DENKO CORP (JP) | 2021-01-27 | — | — | EP | disclosed |
| CN-107428540-B | Functionalized graphene barrier elements | 日东电工株式会社 | 2020-05-12 | — | — | CN | disclosed |
| US-9969682-B2 | Functionalized graphene barrier element | NITTO DENKO CORPORATION (JP) | 2018-05-15 | — | — | US | disclosed |
| EP-3271289-A1 | FUNCTIONALIZED GRAPHENE BARRIER ELEMENT | Nitto Denko Corporation (JP) | 2018-01-24 | — | — | EP | disclosed |
| WO-2016149532-A1 | FUNCTIONALIZED GRAPHENE BARRIER ELEMENT | NITTO DENKO CORPORATION (JP) | 2016-09-22 | — | — | WO | disclosed |
| US-20160272575-A1 | Functionalized Graphene Barrier Element | NITTO DENKO CORPORATION (JP) | 2016-09-22 | — | — | US | disclosed |
| EP-2295438-B1 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | TOSOH CORP (JP) | 2015-03-18 | — | — | EP | disclosed |
| US-8513318-B2 | Method for producing a rigid polyurethane foam | TOSOH CORPORATION (JP) | 2013-08-20 | — | — | US | disclosed |
| US-20110077376-A1 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING IT | TOSOH CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
| EP-2295438-A1 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | Tosoh Corporation (JP) | 2011-03-16 | — | — | EP | disclosed |
| US-7183331-B2 | Method for producing a rigid polyurethane foam | TOSOH CORPORATION (JP) | 2007-02-27 | — | — | US | disclosed |
| US-20070021517-A1 | Method for producing a rigid polyurethane foam | TOSOH CORPORATION (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20040162360-A1 | Method for producing a rigid polyurethane foam | TOSOH CORPORATION (JP) | 2004-08-19 | — | — | US | disclosed |
| US-6777456-B2 | REACTING POLYOL WITH POLYISOCYANATE IN PRESENCE OF AMINE CATALYST AND BLOWING AGENT, WHEREIN AS AMINE CATALYST, AMINE COMPOUND HAVING SUBSTITUENT SELECTED FROM HYDROXYL GROUP, PRIMARY AMINO GROUP AND SECONDARY AMINO GROUP IS USED | TOSOH CORPORATION (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20030083393-A1 | Method for producing a rigid polyurethane foam | TOSOH CORPORATION (JP) | 2003-05-01 | — | — | US | disclosed |
| EP-1273604-A1 | Method for producing a rigid polyurethane foam | Tosoh Corporation (JP) | 2003-01-08 | — | — | EP | disclosed |
| US-5397796-A | Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces | CASSELLA AG (DE) | 1995-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160272575-A1 | Functionalized Graphene Barrier Element | EPCAM, VIM, GPX4 | PAOX 1816/4885HIF1A 928/4885KDM4E 3788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.